更多...
收起
The protein encoded by this gene is a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion and migration. It is a receptor for hyaluronic acid (HA) and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). This protein participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms, however, the full length nature of some of these variants has not been determined. Alternative splicing is the basis for the structural and functional diversity of this protein, and may be related to tumor metastasis. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):]  由该基因编码的蛋白质是参与细胞 - 细胞相互作用,细胞粘附和迁移的细胞表面糖蛋白。它是透明质酸(HA)的受体,也可以与其它配位体,如骨桥蛋白,胶原,和基质金属蛋白酶(MMPs)相互作用。该蛋白参与了多种细胞功能,包括淋巴细胞的活化,再循环和归巢,造血和肿瘤转移。此基因的转录进行复杂的可变剪接,其导致许多功能不同的同种型,但是,其中的一些变体的全长性质尚未确定。选择性剪接是该蛋白质的结构和功能多样性的基础,并且可能与肿瘤转移。 [由RefSeq的,2008年7月提供]
CD44基因(以及对应的蛋白质)的细胞分布位置:
CD44基因的本体(GO)信息:
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Neoplasm Metastasis | 0.193600473 | 236 | 0 | BeFree_CTD_human_LHGDN |
| Stomach Neoplasms | 0.125991584 | 5 | 0 | BeFree_CTD_human_LHGDN |
| Leukemia, Myelocytic, Acute | 0.125981653 | 13 | 0 | BeFree_CTD_human_LHGDN |
| Acute Promyelocytic Leukemia | 0.12272435 | 3 | 0 | CTD_human_LHGDN |
| Pancreatic Neoplasm | 0.120814326 | 4 | 0 | BeFree_CTD_human |
| Dermatologic disorders | 0.120542884 | 3 | 0 | BeFree_CTD_human |
| Contact Dermatitis | 0.12 | 1 | 0 | CTD_human |
| IGA Glomerulonephritis | 0.12 | 1 | 0 | CTD_human |
| Mammary Neoplasms, Experimental | 0.12 | 1 | 0 | CTD_human |
| Nerve Degeneration | 0.12 | 1 | 0 | CTD_human |
| Peripheral Neuropathy | 0.12 | 1 | 0 | CTD_human |
| Vitiligo | 0.12 | 1 | 0 | CTD_human |
| Arsenic Poisoning | 0.12 | 1 | 0 | CTD_human |
| Acute kidney injury | 0.12 | 1 | 0 | CTD_human |
| Cerebrovascular accident | 0.082367032 | 1 | 1 | GAD_RGD |
| Borna Disease | 0.08 | 1 | 0 | RGD |
| Cholestasis | 0.08 | 1 | 0 | RGD |
| Cardiomegaly | 0.08 | 1 | 0 | RGD |
| Kidney Calculi | 0.08 | 1 | 0 | RGD |
| Reperfusion Injury | 0.08 | 2 | 0 | RGD |
| Arthritis, Experimental | 0.08 | 1 | 0 | RGD |
| Malignant neoplasm of breast | 0.03684015 | 127 | 0 | BeFree_GAD |
| Breast Carcinoma | 0.035016001 | 129 | 0 | BeFree |
| Mammary Neoplasms | 0.029938058 | 37 | 0 | BeFree_LHGDN |
| Squamous cell carcinoma | 0.021493566 | 33 | 1 | BeFree_LHGDN |
| melanoma | 0.017140564 | 24 | 0 | BeFree_LHGDN |
| Tumor Progression | 0.016557954 | 61 | 0 | BeFree |
| Colorectal Carcinoma | 0.014657861 | 54 | 0 | BeFree |
| Colorectal Neoplasms | 0.013340378 | 13 | 0 | BeFree_LHGDN |
| Malignant neoplasm of prostate | 0.01302921 | 48 | 0 | BeFree |
| Prostate carcinoma | 0.012757768 | 47 | 0 | BeFree |
| Colonic Neoplasms | 0.012526052 | 10 | 0 | BeFree_LHGDN |
| Carcinogenesis | 0.012214884 | 45 | 1 | BeFree |
| Stomach Carcinoma | 0.012214884 | 45 | 0 | BeFree |
| Colorectal Cancer | 0.012214884 | 45 | 0 | BeFree |
| Colon Carcinoma | 0.011672 | 43 | 0 | BeFree |
| Malignant neoplasm of stomach | 0.011400559 | 42 | 0 | BeFree |
| Malignant neoplasm of ovary | 0.009967404 | 29 | 0 | BeFree_GAD |
| Liver carcinoma | 0.008967513 | 24 | 0 | BeFree_LHGDN |
| Ovarian Carcinoma | 0.00868614 | 32 | 0 | BeFree |
| Glioma | 0.00842463 | 22 | 0 | BeFree_LHGDN |
| Bladder Neoplasm | 0.008173051 | 3 | 0 | LHGDN |
| Carcinoma, Transitional Cell | 0.007891677 | 9 | 0 | BeFree_LHGDN |
| Pancreatic carcinoma | 0.007600372 | 28 | 0 | BeFree |
| ovarian neoplasm | 0.007348794 | 8 | 0 | BeFree_LHGDN |
| Lung Neoplasms | 0.007077352 | 8 | 0 | BeFree_LHGDN |
| Lymphoma | 0.00706742 | 17 | 0 | BeFree_LHGDN |
| Malignant tumor of colon | 0.007057489 | 26 | 0 | BeFree |
| Prostatic Neoplasms | 0.00680591 | 7 | 0 | BeFree_LHGDN |
| Multiple Myeloma | 0.006795978 | 15 | 0 | BeFree_LHGDN |
| Atherosclerosis | 0.006534468 | 5 | 0 | BeFree_LHGDN |
| Non-Small Cell Lung Carcinoma | 0.006253095 | 14 | 0 | BeFree_LHGDN |
| Rheumatoid Arthritis | 0.005710211 | 11 | 0 | BeFree_LHGDN |
| Neuroblastoma | 0.005700279 | 21 | 0 | BeFree |
| Secondary malignant neoplasm of lymph node | 0.005700279 | 21 | 0 | BeFree |
| Inflammation | 0.0054487 | 2 | 0 | LHGDN |
| oligodendroglioma | 0.0054487 | 2 | 0 | LHGDN |
| Infection | 0.0054487 | 2 | 0 | LHGDN |
| Arthritis | 0.005362824 | 3 | 0 | BeFree_GAD_LHGDN |
| Malignant neoplasm of pancreas | 0.005157396 | 19 | 0 | BeFree |
| Central neuroblastoma | 0.005157396 | 19 | 0 | BeFree |
| Head and Neck Neoplasms | 0.005091382 | 2 | 0 | GAD_LHGDN |
| Squamous cell carcinoma of the head and neck | 0.004614512 | 17 | 0 | BeFree |
| Adenocarcinoma | 0.00434307 | 16 | 0 | BeFree |
| Osteosarcoma | 0.00408156 | 6 | 0 | BeFree_LHGDN |
| Lupus Erythematosus, Systemic | 0.003995683 | 6 | 0 | BeFree_GAD |
| Endometriosis | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| Epstein-Barr Virus Infections | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| Glioblastoma | 0.003528744 | 13 | 0 | BeFree |
| Gastrointestinal Stromal Tumors | 0.003267234 | 3 | 0 | BeFree_LHGDN |
| Malignant neoplasm of lung | 0.003257302 | 12 | 0 | BeFree |
| Epithelial ovarian cancer | 0.003257302 | 12 | 0 | BeFree |
| Lupus Erythematosus, Discoid | 0.003181358 | 3 | 0 | BeFree_GAD |
| Crohn Disease | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| keratoacanthoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Acute monocytic leukemia | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Multiple Sclerosis | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Nephroblastoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Aortic Aneurysm, Abdominal | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Smooth Muscle Tumor | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Lymphangioleiomyomatosis | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| leukemia | 0.002985861 | 11 | 0 | BeFree |
| Carcinoma of lung | 0.002985861 | 11 | 0 | BeFree |
| Lupus Vulgaris | 0.002909916 | 2 | 0 | BeFree_GAD |
| Lupus Erythematosus | 0.002909916 | 2 | 0 | BeFree_GAD |
| Biliary Tract Neoplasm | 0.00272435 | 1 | 0 | LHGDN |
| Encephalomyelitis | 0.00272435 | 1 | 0 | LHGDN |
| Endometrial Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Laryngeal neoplasm | 0.00272435 | 1 | 0 | LHGDN |
| Acute Erythroblastic Leukemia | 0.00272435 | 1 | 0 | LHGDN |
| Rectal Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Lichen Planus, Oral | 0.00272435 | 1 | 0 | LHGDN |
| Carcinoma, Neuroendocrine | 0.00272435 | 1 | 0 | LHGDN |
| Papilloma, Intraductal | 0.00272435 | 1 | 0 | LHGDN |
| Brain Neoplasms | 0.002714419 | 10 | 0 | BeFree |
| HIV Infections | 0.002442977 | 9 | 0 | BeFree |
| Cancer of Head and Neck | 0.002442977 | 9 | 0 | BeFree |
| Endometrial Carcinoma | 0.002442977 | 9 | 0 | BeFree |
| Congenital Heart Defects | 0.002367032 | 1 | 0 | GAD |
| Hepatitis B | 0.002367032 | 1 | 0 | GAD |
| Neoplasm Recurrence, Local | 0.002367032 | 1 | 0 | GAD |
| Neoplasms, Second Primary | 0.002367032 | 1 | 0 | GAD |
| Drug-Induced Liver Injury | 0.002367032 | 1 | 0 | GAD |
| Malignant neoplasm of endometrium | 0.002171535 | 8 | 0 | BeFree |
| Secondary malignant neoplasm of liver | 0.002171535 | 8 | 0 | BeFree |
| Carcinoma of bladder | 0.002171535 | 8 | 0 | BeFree |
| Uterine Corpus Cancer | 0.002171535 | 8 | 0 | BeFree |
| Triple Negative Breast Neoplasms | 0.002171535 | 8 | 0 | BeFree |
| Adenoma | 0.001900093 | 7 | 0 | BeFree |
| Chronic Lymphocytic Leukemia | 0.001900093 | 7 | 0 | BeFree |
| Recurrent tumor | 0.001900093 | 7 | 0 | BeFree |
| Thyroid carcinoma | 0.001900093 | 7 | 0 | BeFree |
| Sarcoma | 0.001900093 | 7 | 0 | BeFree |
| Adenoma of large intestine | 0.001900093 | 7 | 0 | BeFree |
| Nasopharyngeal carcinoma | 0.001900093 | 7 | 2 | BeFree |
| Malignant neoplasm of urinary bladder | 0.001628651 | 6 | 0 | BeFree |
| Secondary malignant neoplasm of bone | 0.001628651 | 6 | 0 | BeFree |
| Solid tumour | 0.001628651 | 6 | 0 | BeFree |
| Adenocarcinoma of pancreas | 0.001628651 | 6 | 0 | BeFree |
| Cervix carcinoma | 0.001628651 | 6 | 0 | BeFree |
| Hematologic Neoplasms | 0.001628651 | 6 | 0 | BeFree |
| Astrocytoma | 0.001357209 | 5 | 0 | BeFree |
| Renal Cell Carcinoma | 0.001357209 | 5 | 0 | BeFree |
| Malignant tumor of cervix | 0.001357209 | 5 | 0 | BeFree |
| Acute lymphocytic leukemia | 0.001357209 | 5 | 0 | BeFree |
| Liver neoplasms | 0.001357209 | 5 | 0 | BeFree |
| Adenocarcinoma of lung (disorder) | 0.001357209 | 5 | 0 | BeFree |
| Metastatic malignant neoplasm to brain | 0.001357209 | 5 | 0 | BeFree |
| Gallbladder Carcinoma | 0.001357209 | 5 | 0 | BeFree |
| Gastric Adenocarcinoma | 0.001357209 | 5 | 0 | BeFree |
| Osteosarcoma of bone | 0.001357209 | 5 | 0 | BeFree |
| Brain Tumor, Primary | 0.001357209 | 5 | 0 | BeFree |
| Non-Neoplastic Disorder | 0.001357209 | 5 | 0 | BeFree |
| Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.001357209 | 5 | 0 | BeFree |
| Anaplasia | 0.001085767 | 4 | 0 | BeFree |
| Arteriosclerosis | 0.001085767 | 4 | 0 | BeFree |
| Autoimmune Diseases | 0.001085767 | 4 | 0 | BeFree |
| Rectal Carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Diabetic Nephropathy | 0.001085767 | 4 | 0 | BeFree |
| Immunologic Deficiency Syndromes | 0.001085767 | 4 | 0 | BeFree |
| Mesothelioma | 0.001085767 | 4 | 0 | BeFree |
| Degenerative polyarthritis | 0.001085767 | 4 | 0 | BeFree |
| Severe Combined Immunodeficiency | 0.001085767 | 4 | 0 | BeFree |
| Small cell carcinoma of lung | 0.001085767 | 4 | 0 | BeFree |
| Lip and Oral Cavity Carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Papillary thyroid carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Liver and Intrahepatic Biliary Tract Carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Adenocarcinoma of colon | 0.001085767 | 4 | 0 | BeFree |
| Malignant neoplasm of liver | 0.001085767 | 4 | 0 | BeFree |
| Malignant Glioma | 0.001085767 | 4 | 0 | BeFree |
| Tumor Initiation | 0.001085767 | 4 | 0 | BeFree |
| Epithelioma | 0.001085767 | 4 | 0 | BeFree |
| Noninfiltrating Intraductal Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Carcinoma, Papillary | 0.000814326 | 3 | 0 | BeFree |
| Fibrosarcoma | 0.000814326 | 3 | 0 | BeFree |
| Ganglioneuroma | 0.000814326 | 3 | 0 | BeFree |
| Gastrointestinal Neoplasms | 0.000814326 | 3 | 0 | BeFree |
| Inflammatory Bowel Diseases | 0.000814326 | 3 | 0 | BeFree |
| Lymphatic Metastasis | 0.000814326 | 3 | 0 | BeFree |
| Meningioma | 0.000814326 | 3 | 0 | BeFree |
| Neurofibromatosis 2 | 0.000814326 | 3 | 0 | BeFree |
| Obesity | 0.000814326 | 3 | 0 | BeFree |
| Pleural effusion disorder | 0.000814326 | 3 | 0 | BeFree |
| Pneumonia | 0.000814326 | 3 | 0 | BeFree |
| Precancerous Conditions | 0.000814326 | 3 | 0 | BeFree |
| B-Cell Lymphomas | 0.000814326 | 3 | 0 | BeFree |
| Diffuse Large B-Cell Lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of mouth | 0.000814326 | 3 | 0 | BeFree |
| Secondary malignant neoplasm of lung | 0.000814326 | 3 | 0 | BeFree |
| Adenomatous Polyps | 0.000814326 | 3 | 0 | BeFree |
| Carcinoma, Large Cell | 0.000814326 | 3 | 0 | BeFree |
| Squamous cell carcinoma of skin | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of kidney | 0.000814326 | 3 | 0 | BeFree |
| Malignant Peripheral Nerve Sheath Tumor | 0.000814326 | 3 | 0 | BeFree |
| SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1 | 0.000814326 | 3 | 0 | BeFree |
| Metastatic Prostate Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| High-Grade Prostatic Intraepithelial Neoplasia | 0.000814326 | 3 | 0 | BeFree |
| Adenocarcinoma of large intestine | 0.000814326 | 3 | 0 | BeFree |
| Renal carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Cancer Cell Growth | 0.000814326 | 3 | 0 | BeFree |
| Glioblastoma Multiforme | 0.000814326 | 3 | 0 | BeFree |
| Congenital dyserythropoietic anemia | 0.000542884 | 2 | 0 | BeFree |
| Asthma | 0.000542884 | 2 | 0 | BeFree |
| Burkitt Lymphoma | 0.000542884 | 2 | 0 | BeFree |
| Carcinoid Tumor | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of larynx | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of skin | 0.000542884 | 2 | 0 | BeFree |
| Cardiovascular Diseases | 0.000542884 | 2 | 0 | BeFree |
| Ulcerative Colitis | 0.000542884 | 2 | 0 | BeFree |
| Diabetes Mellitus, Non-Insulin-Dependent | 0.000542884 | 2 | 0 | BeFree |
| Gastritis, Atrophic | 0.000542884 | 2 | 0 | BeFree |
| Myeloid Leukemia | 0.000542884 | 2 | 0 | BeFree |
| Leukemia, T-Cell | 0.000542884 | 2 | 0 | BeFree |
| Lymphoproliferative Disorders | 0.000542884 | 2 | 0 | BeFree |
| Mycoses | 0.000542884 | 2 | 0 | BeFree |
| Pituitary Adenoma | 0.000542884 | 2 | 0 | BeFree |
| Precocious Puberty | 0.000542884 | 2 | 0 | BeFree |
| Retinoblastoma | 0.000542884 | 2 | 0 | BeFree |
| Synovitis | 0.000542884 | 2 | 0 | BeFree |
| Thyroid Neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Hallopeau-Siemens Disease | 0.000542884 | 2 | 0 | BeFree |
| Benign Neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Cutaneous Melanoma | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of gallbladder | 0.000542884 | 2 | 0 | BeFree |
| Cholangiocarcinoma | 0.000542884 | 2 | 0 | BeFree |
| Cervical Intraepithelial Neoplasia | 0.000542884 | 2 | 0 | BeFree |
| Ganglioneuroblastoma | 0.000542884 | 2 | 0 | BeFree |
| Neuroendocrine Tumors | 0.000542884 | 2 | 0 | BeFree |
| Malignant ascites | 0.000542884 | 2 | 0 | BeFree |
| Fibrosis, Liver | 0.000542884 | 2 | 0 | BeFree |
| Carcinoma, Small Cell | 0.000542884 | 2 | 0 | BeFree |
| Epithelial hyperplasia of skin | 0.000542884 | 2 | 0 | BeFree |
| Carcinoma breast stage IV | 0.000542884 | 2 | 0 | BeFree |
| Squamous cell carcinoma of oropharynx | 0.000542884 | 2 | 0 | BeFree |
| Carcinoid tumor no ICD-O subtype | 0.000542884 | 2 | 0 | BeFree |
| Glaucoma, Primary Open Angle | 0.000542884 | 2 | 0 | BeFree |
| Intrahepatic Cholangiocarcinoma | 0.000542884 | 2 | 0 | BeFree |
| Disseminated Malignant Neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000542884 | 2 | 0 | BeFree |
| Nephrolithiasis | 0.000542884 | 2 | 0 | BeFree |
| Immune thrombocytopenic purpura | 0.000542884 | 2 | 0 | BeFree |
| Carcinoma of larynx | 0.000542884 | 2 | 0 | BeFree |
| Malignant Pleural Mesothelioma | 0.000542884 | 2 | 0 | BeFree |
| Invasive breast carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Cutaneous lymphoma | 0.000542884 | 2 | 0 | BeFree |
| Precursor B-cell lymphoblastic leukemia | 0.000542884 | 2 | 0 | BeFree |
| Skin Carcinogenesis | 0.000542884 | 2 | 0 | BeFree |
| Xenograft Model | 0.000542884 | 2 | 0 | BeFree |
| Non-Malignant Ascites Adverse Event | 0.000542884 | 2 | 0 | BeFree |
| Benign Prostatic Hyperplasia | 0.000542884 | 2 | 0 | BeFree |
| Plaque, Amyloid | 0.000542884 | 2 | 0 | BeFree |
| Overgrowth Syndrome | 0.000542884 | 2 | 0 | BeFree |
| Experimental Organism Basal Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Adrenal Gland Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Alzheimer's Disease | 0.000271442 | 1 | 0 | BeFree |
| Bowen's Disease | 0.000271442 | 1 | 0 | BeFree |
| Bronchopulmonary Dysplasia | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma of prostate | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of thyroid | 0.000271442 | 1 | 0 | BeFree |
| Cholera | 0.000271442 | 1 | 0 | BeFree |
| Hepatic Fibrosis, Congenital | 0.000271442 | 1 | 0 | BeFree |
| Coronary Thrombosis | 0.000271442 | 1 | 0 | BeFree |
| Cryptorchidism | 0.000271442 | 1 | 0 | BeFree |
| Adenoid Cystic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Cyst | 0.000271442 | 1 | 0 | BeFree |
| Scleroderma | 0.000271442 | 1 | 0 | BeFree |
| Diabetes | 0.000271442 | 1 | 0 | BeFree |
| Diabetes Mellitus | 0.000271442 | 1 | 0 | BeFree |
| Exanthema | 0.000271442 | 1 | 0 | BeFree |
| Hereditary Multiple Exostoses | 0.000271442 | 1 | 0 | BeFree |
| Fatty Liver | 0.000271442 | 1 | 0 | BeFree |
| Gastrinoma | 0.000271442 | 1 | 0 | BeFree |
| Heart failure | 0.000271442 | 1 | 0 | BeFree |
| Congestive heart failure | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis C | 0.000271442 | 1 | 0 | BeFree |
| Hyperlipoproteinemia Type III | 0.000271442 | 1 | 0 | BeFree |
| Mammary Ductal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Arthropathy | 0.000271442 | 1 | 0 | BeFree |
| Lymphoid leukemia | 0.000271442 | 1 | 0 | BeFree |
| Leukemia, Lymphocytic, Acute, L1 | 0.000271442 | 1 | 0 | BeFree |
| Myeloid Leukemia, Chronic | 0.000271442 | 1 | 0 | BeFree |
| Adult T-Cell Lymphoma/Leukemia | 0.000271442 | 1 | 0 | BeFree |
| Lung diseases | 0.000271442 | 1 | 0 | BeFree |
| Lupus Nephritis | 0.000271442 | 1 | 0 | BeFree |
| Lymphocytic Choriomeningitis | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma, Non-Hodgkin | 0.000271442 | 1 | 0 | BeFree |
| Marfan Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Mixed Salivary Gland Tumor | 0.000271442 | 1 | 0 | BeFree |
| Neurilemmoma | 0.000271442 | 1 | 0 | BeFree |
| neurofibroma | 0.000271442 | 1 | 0 | BeFree |
| Nodule | 0.000271442 | 1 | 0 | BeFree |
| Osteoporosis | 0.000271442 | 1 | 0 | BeFree |
| Ovarian Cysts | 0.000271442 | 1 | 0 | BeFree |
| Periodontitis | 0.000271442 | 1 | 0 | BeFree |
| Polycystic Ovary Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Adenomatous Polyposis Coli | 0.000271442 | 1 | 0 | BeFree |
| Pulmonary Fibrosis | 0.000271442 | 1 | 0 | BeFree |
| Systemic Scleroderma | 0.000271442 | 1 | 0 | BeFree |
| Seizures | 0.000271442 | 1 | 0 | BeFree |
| Seminoma | 0.000271442 | 1 | 0 | BeFree |
| Skin Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Thromboangiitis Obliterans | 0.000271442 | 1 | 0 | BeFree |
| Thymoma | 0.000271442 | 1 | 0 | BeFree |
| Tic disorder | 0.000271442 | 1 | 0 | BeFree |
| Urologic Diseases | 0.000271442 | 1 | 0 | BeFree |
| Varicose Ulcer | 0.000271442 | 1 | 0 | BeFree |
| Virilism | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma, Small Noncleaved-Cell | 0.000271442 | 1 | 0 | BeFree |
| T-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Peripheral T-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Pleural Effusion, Malignant | 0.000271442 | 1 | 0 | BeFree |
| Ovarian Hyperstimulation Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Ovarian Failure, Premature | 0.000271442 | 1 | 0 | BeFree |
| Li-Fraumeni Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Esophageal carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Non-arthropod borne lymphocytic choriomeningitis | 0.000271442 | 1 | 0 | BeFree |
| Adrenoleukodystrophy | 0.000271442 | 1 | 0 | BeFree |
| Neurofibromatoses | 0.000271442 | 1 | 0 | BeFree |
| Germ cell tumor | 0.000271442 | 1 | 0 | BeFree |
| Hepatoblastoma | 0.000271442 | 1 | 0 | BeFree |
| Nerve Sheath Tumors | 0.000271442 | 1 | 0 | BeFree |
| Combined Hepatocellular Carcinoma and Cholangiocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Incoherent thinking | 0.000271442 | 1 | 0 | BeFree |
| Female Pseudohermaphroditism | 0.000271442 | 1 | 0 | BeFree |
| Male Pseudohermaphroditism | 0.000271442 | 1 | 0 | BeFree |
| Anaplastic thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Islet Cell Tumor | 0.000271442 | 1 | 0 | BeFree |
| Proliferative vitreoretinopathy | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma of ampulla of Vater | 0.000271442 | 1 | 0 | BeFree |
| Simple renal cyst | 0.000271442 | 1 | 0 | BeFree |
| Endometrioma | 0.000271442 | 1 | 0 | BeFree |
| Behavioral tic | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of colon stage IV | 0.000271442 | 1 | 0 | BeFree |
| Breast cancer recurrent | 0.000271442 | 1 | 0 | BeFree |
| Non-small cell lung cancer stage I | 0.000271442 | 1 | 0 | BeFree |
| Cervix carcinoma stage III | 0.000271442 | 1 | 0 | BeFree |
| Cervical carcinoma stage IB | 0.000271442 | 1 | 0 | BeFree |
| Ovarian epithelial cancer recurrent | 0.000271442 | 1 | 0 | BeFree |
| Disseminated neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
| Metastatic melanoma | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of esophagus | 0.000271442 | 1 | 0 | BeFree |
| Conventional (Clear Cell) Renal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Juvenile Pilocytic Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of vulva | 0.000271442 | 1 | 0 | BeFree |
| Superficial ulcer | 0.000271442 | 1 | 0 | BeFree |
| Nodular melanoma | 0.000271442 | 1 | 0 | BeFree |
| Gliomatosis cerebri | 0.000271442 | 1 | 0 | BeFree |
| Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.000271442 | 1 | 0 | BeFree |
| Thyroid associated opthalmopathies | 0.000271442 | 1 | 0 | BeFree |
| Breast Cancer, Familial | 0.000271442 | 1 | 0 | BeFree |
| Early gastric cancer | 0.000271442 | 1 | 0 | BeFree |
| Pouchitis | 0.000271442 | 1 | 0 | BeFree |
| Developmental delay (disorder) | 0.000271442 | 1 | 0 | BeFree |
| Adamantinous Craniopharyngioma | 0.000271442 | 1 | 0 | BeFree |
| Acute monoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
| Pneumonia due to Klebsiella pneumoniae | 0.000271442 | 1 | 0 | BeFree |
| Mixed cryoglobulinemia | 0.000271442 | 1 | 0 | BeFree |
| Costello syndrome (disorder) | 0.000271442 | 1 | 0 | BeFree |
| Leukemogenesis | 0.000271442 | 1 | 0 | BeFree |
| Lymphoid neoplasm | 0.000271442 | 1 | 0 | BeFree |
| CARCINOMA OF VULVA | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of gastrointestinal tract | 0.000271442 | 1 | 0 | BeFree |
| Subfertility | 0.000271442 | 1 | 0 | BeFree |
| Bile duct carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Premenopausal breast cancer | 0.000271442 | 1 | 0 | BeFree |
| infertility tubal factor | 0.000271442 | 1 | 0 | BeFree |
| Pharyngeal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| early pregnancy | 0.000271442 | 1 | 0 | BeFree |
| Cleft Lip with or without Cleft Palate | 0.000271442 | 1 | 0 | BeFree |
| Spots on skin | 0.000271442 | 1 | 0 | BeFree |
| Hypospadias | 0.000271442 | 1 | 0 | BeFree |
| Adenomatous polyp of colon | 0.000271442 | 1 | 0 | BeFree |
| Helicobacter pylori infection | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma in situ of uterine cervix | 0.000271442 | 1 | 0 | BeFree |
| Pneumonia due to Gram negative bacteria | 0.000271442 | 1 | 0 | BeFree |
| Pancreatic adenocarcinoma metastatic | 0.000271442 | 1 | 0 | BeFree |
| precancerous lesions | 0.000271442 | 1 | 0 | BeFree |
| Colorectal cancer metastatic | 0.000271442 | 1 | 0 | BeFree |
| Polyp of large intestine | 0.000271442 | 1 | 0 | BeFree |
| Hurthle Cell Tumor | 0.000271442 | 1 | 0 | BeFree |
| Invasive Ductal Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Mammary Carcinoma, Human | 0.000271442 | 1 | 0 | BeFree |
| Urban Schosser Spohn syndrome | 0.000271442 | 1 | 0 | BeFree |
| Chronic inflammatory disorder | 0.000271442 | 1 | 0 | BeFree |
| Pancreatic intraepithelial neoplasia | 0.000271442 | 1 | 0 | BeFree |
| Astrocytoma, low grade | 0.000271442 | 1 | 0 | BeFree |
| Aggressive Non-Hodgkin Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Perianal Squamous Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
| Invasive Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Pancreatic Ductal Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma of urinary bladder, superficial | 0.000271442 | 1 | 0 | BeFree |
| Conn Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Desmoplastic | 0.000271442 | 1 | 0 | BeFree |
| Salivary Gland Pleomorphic Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Tumor Promotion | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma, Endometrioid | 0.000271442 | 1 | 0 | BeFree |
| Penile hypospadias | 0.000271442 | 1 | 0 | BeFree |
| Idiopathic Pulmonary Fibrosis | 0.000271442 | 1 | 0 | BeFree |
| Omodysplasia type 1 | 0.000271442 | 1 | 0 | BeFree |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Urothelial Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Steatohepatitis | 0.000271442 | 1 | 0 | BeFree |
| Neural crest tumor | 0.000271442 | 1 | 0 | BeFree |
| Early-Stage Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Mammary adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。